Health Tech Capitol | Cellectar, Onconova Therapeutics Collaborate
15983
post-template-default,single,single-post,postid-15983,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Cellectar, Onconova Therapeutics Collaborate

21 Sep Cellectar, Onconova Therapeutics Collaborate

Posted at 12:56h in Uncategorized by
0 Likes

Cellectar Biosciences announced today it has entered into a strategic collaboration with Onconova Therapeutics, a biopharmaceutical company, to develop new phospholipid drug conjugates (PDC).

According to a release, the Newtown, Pa.-based Onconova will provide Cellectar with several compounds, and Cellectar will link the molecules to its PDC platform to create new antitumor agents.

Read more at Madison Startups

No Comments

Sorry, the comment form is closed at this time.